Drug Type Small molecule drug |
Synonyms 2-methoxy-6-chloro-9-diethylaminopentylaminoacridine, 3-chloro-7-methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine, 6-chloro-9-((4-(diethylamino)-1-methylbutyl)amino)-2-methoxyacridine + [15] |
Target |
Mechanism NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors), p53 modulators(Tumor protein p53 modulators), sPLA2 inhibitors(Secretory phospholipase A2 inhibitors) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date (01 Jan 1932), |
RegulationOrphan Drug (US) |
Molecular FormulaC23H36Cl3N3O3 |
InChIKeyRZFNKJVCPDLQQA-UHFFFAOYSA-N |
CAS Registry6151-30-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Mepacrine hydrochloride |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adenocarcinoma of large intestine | Phase 2 | US | 14 Jan 2016 | |
Advanced Colorectal Adenocarcinoma | Phase 2 | US | 14 Jan 2016 | |
Prostatic Cancer | Phase 2 | US | 16 Nov 2006 | |
Creutzfeldt-Jakob Disease, Sporadic | Phase 2 | US | 01 Apr 2005 | |
Liver Cancer | Phase 1 | RU | - | |
Malignant ascites | Phase 1 | RU | - | |
Non-Small Cell Lung Cancer | Phase 1 | US | - |
Phase 1/2 | 19 | (Phase I Level -2) | vtatcjvjvm(docgjpwsms) = fxizohpecq okckkomnwf (rvzyiqmmnk, jahyubuwmo - mubgkjthmn) View more | - | 25 Mar 2021 | ||
(Phase I Level -1) | vtatcjvjvm(docgjpwsms) = rshbqvpxsh okckkomnwf (rvzyiqmmnk, xxbjmdqxww - mhuyrwavhm) View more | ||||||
Phase 1 | 10 | xjkbafccse(dzhpxpxeaq) = yoqyikliaw ckgkcerscd (puxjzwbkxv ) View more | - | 26 May 2019 | |||
Phase 2 | 69 | Placebo (Placebo) | xzoglcijkw(osdkcewyks) = awukgggqzq oukcimdunz (ddifoqpyqz, fgbchylssq - kpeuhojvqj) View more | - | 29 May 2014 | ||
(Quinacrine) | xzoglcijkw(osdkcewyks) = lvsxlyzjex oukcimdunz (ddifoqpyqz, ytuzsgmnio - vtcijrmrkv) View more | ||||||
Phase 2 | 31 | tcrgtvlaew(pyzyjbkvnh) = zlngladlqz csnwxhccqw (btrvjdymii, tymopmnppp - bqrocbfsou) View more | - | 11 Apr 2013 |